FTSE 100: Index falls as earnings results weigh; pound below $1.33, Bodycote soars
On March 6, John Jude Jones, Chief Marketing Officer of Marsh & McLennan Companies, Inc. (NYSE:MMC), sold a significant portion of his holdings in the company. According to a recent SEC filing, Jones sold a total of 10,824 shares of common stock, with the transactions executed at prices ranging from $234.8396 to $235.605 per share. The total value of these sales amounted to approximately $2,545,205.
In addition to these sales, Jones exercised stock options to acquire 9,800 shares at prices between $117.53 and $118.865 per share, totaling $1,158,125. Following these transactions, Jones holds 7,978 shares directly. The company has demonstrated strong shareholder returns, maintaining dividend payments for 55 consecutive years with a current yield of 1.38%.
These transactions reflect typical activities for corporate executives managing their portfolios and exercising stock options. Marsh & McLennan, a global professional services firm, continues to be a key player in the insurance and risk management sector.
In other recent news, Marsh & McLennan reported its fourth-quarter 2024 financial results, exceeding analysts’ expectations. The company posted an adjusted earnings per share (EPS) of $1.87, surpassing the forecast of $1.77, and revenue of $6.07 billion, which also beat the projected $5.93 billion. The results reflect a 9% year-over-year increase in revenue. In a strategic move, Marsh & McLennan announced the acquisition of SECOR Asset Management, a firm with $21.5 billion in assets under management, expected to close in the second quarter of 2025. This acquisition aims to bolster Marsh & McLennan’s investment solutions for institutional investors.
Analysts have provided mixed evaluations of Marsh & McLennan’s prospects. Raymond (NSE:RYMD) James raised the company’s price target to $250, maintaining a Strong Buy rating, while Keefe, Bruyette & Woods lowered their target to $210, citing expected lower margins. Meanwhile, Goldman Sachs maintained a Sell rating with a price target of $204, pointing to challenges in achieving growth and margin estimates. Despite these varied assessments, Marsh & McLennan continues to focus on expanding its global reach and improving operational efficiencies, with planned capital deployment of $4.5 billion for 2025. These developments indicate Marsh & McLennan’s ongoing efforts to strengthen its market position and financial performance.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.